NCBiotech News

Brii Biosciences is plowing ahead with its clinical development programs after landing a whooping $155 million in funding.

After considering other cities and states, global ag giant Syngenta has decided to keep its North American Crop Protection headquarters in Greensboro, where it will invest $68 million to renovate aging labs and build a new office building to support its 650 employees and 100 contract workers.

Cary-based Chiesi USA has launched its Bronchitol (mannitol) inhalation powder following approval by the FDA, opening treatment options for adults with cystic fibrosis.

Raybow USA, a custom chemical research and development company in the western North Carolina city of Brevard, has announced plans to invest $15.8 million over the next five years in an expansion that will add 74 employees to its current workforce of 26.

Baebies, a Durham company specializing in disorder screening for newborns, has reached a milestone of 10 million tests delivered to labs since its founding in 2014 was bootstrapped by an early loan from the North Carolina Biotechnology Center.

FUJIFILM Corporation today ended a high-stakes economic development drama by announcing that Holly Springs, N.C., is officially its choice for siting a $2 billion biomanufacturing site that will employ 725 over five years.

NC State University and Novozymes have been combining forces to produce more than 2,400 gallons of hand sanitizer to help keep NC State students, faculty and staff safer, as well as people at the NC Museum of Natural Sciences in Raleigh.

Global pharmaceutical giant Merck has confirmed that its flagship Durham vaccine manufacturing facility is gearing up to help competitor Johnson & Johnson produce COVID-19 vaccine.

Sign up now for NCBiotech-hosted CRO Career Conversations, to be held March 17 from 6 to 7 p.m. on March 17 with a focus on contract research associates, a key position that is heavily involved in monitoring clinical trials.

Today marks International Women’s Day: a day devoted to celebrating women, their achievements and recognizing the bias that holds many back. The North Carolina life sciences community owes many successes to the women who devote their talents to public health.

Durham’s 410 Medical, Inc. has launched sales in the United States of its LifeFlow PLUS Blood and Fluid Infuser, following its U.S. Food and Drug Administration clearance in 2020.

Biogen has announced a $200 million investment to support clinical production for its gene therapy pipeline. The company plans to add 90 more workers to its workforce of 1,900 people at its two facilities in the Research Triangle Park.

Expansions announced in 2020 will bring more than $2.3 billion in investment and 2,800 new jobs in biopharma manufacturing to North Carolina in coming months and years.

West Pharmaceutical Services, a manufacturer of drug-packaging and delivery components in Kinston for the last four decades, will invest $19 million, add 90 workers over the next year to expand its production capacity there.

Morrisville gene editing startup Locus Biosciences has completed the world’s first clinical trial of a recombinant bacteriophage therapy that also marks the first time a CRISPR-enhanced therapeutic has been administered in a clinical setting.